Interview: Lawrence Gan – President & CEO, Taiwan Development Center for Biotechnology (DCB), Taiwan

Lawrence GanLawrence Gan, President and CEO of Taiwan’s Development Center for Biotechnology (DCB) explains his vision and strategy to enhance DCB’s R&D expertise by adopting some of the best practices of the corporate world. You became head of Taiwan’s Development Center for Biotechnology after having held prestigious positions in the US among some of most innovative biopharmaceutical companies in the world, including GSK, BMS, Boehringer Ingelheim, Takeda, and Biogen. What was the rationale behind your decision to come back to Taiwan?
"Despite being a government-backed NGO on paper, DCB truly operates as a new drug discovery and pre-clinical development company."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report